Our experiments found that after Neo-BCV treatment, only the phosphorylation levels of JAK2 and STAT3 in mice subcutaneous tumor tissues were significantly affected, indicating that Neo-BCV specifically inhibits the phosphorylation of JAK2, thereby suppressing the activation of STAT3. Here, JAK2 is linked to neoplasm.